Long-term survival after cardiac arrest in hypertrophic cardiomyopathy

Heart Rhythm

Volumn 6, Issue 7, 2009, Pages 993-997

  Maron, Barry J ^a   Haas, Tammy S ^a   Shannon, Kevin M ^b   Almquist, Adrian K ^a   Hodges, James S ^c  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cardiac arrest; Cardiomyopathy; Implantable defibrillator; Sudden death; Ventricular fibrillation

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INOTROPIC AGENT; VERAPAMIL;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART ARREST; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 67649132593     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.03.014     Document Type: Article

References (17)

1. Maron B.J., and Spirito P. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 19 (2008) 1118-1126
2. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology Clinical Expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 42 (2003) 1687-1713
3. Maron B.J., Spirito P., Shen W.-K., et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412
4. Elliott P.M., Sharma S., Varnava A., Poloniecki J., Rowland E., and McKenna W.J. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 33 (1999) 1596-1601
5. Elliott P.M., Gimeno Blanes J.R., Mahon N.G., et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357 (2001) 420-424
6. Cecchi F., Maron B.J., and Epstein S.E. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 13 (1989) 1283-1288
7. Morrow A.G., Koch J.P., Maron B.J., Kent K.M., and Epstein S.E. Left ventricular myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy and previous cardiac arrest. Am J Cardiol 46 (1980) 313-316
8. Harris K.M., Spirito P., Maron M.S., et al. Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114 (2006) 216-225
9. Maron B.J., Olivotto I., Spirito P., et al. Epidemiology of hypertrophic cardiomyopathy-related death. Revisited in a large non-referral-based patient population. Circulation 102 (2000) 858-864
10. Maron B.J., Casey S.A., Poliac L.C., Gohman T.E., Almquist A.K., and Aeppli D.M. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 281 (1999) 650-655
11. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
12. Maron B.J., and Roberts W.C. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59 (1979) 689-706
13. Maron B.J., Anan T.J., and Roberts W.C. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 63 (1981) 882-894
14. Varnava A.M., Elliott P.M., Mahon N., Davies M.J., and McKenna W.J. Relation between myocyte disarray and outcomes in hypertrophic cardiomyopathy. Am J Cardiol 88 (2001) 275-279
15. Varnava A.M., Elliott P.M., Baboonian C., Davison F., Davies M.J., and McKenna W.J. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104 (2001) 1380-1384
16. Maron B.J., Wolfson J.K., Epstein S.E., et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8 (1986) 545-557
17. Cha Y.-M., Gersh B.J., Maron B.J., et al. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 18 (2007) 1-5